Health TrialsbyHealthPanel

Effect of TECAR Therapy on Pain, Balance, and Quality of Life in Elderly Men With Knee Osteoarthritis

ConditionKnee Osteoarthritis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age65-75
SponsorMiddle East University

About this trial

Evaluate the effect of TECAR therapy combined with traditional physiotherapy on pain, balance, and quality of life in elderly men with knee osteoarthritis .

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clinical and radiographic diagnosis of mild and moderate bilateral or unilateral knee osteoarthritis meeting the American College of Rheumatology (ACR) criteria.

Presence of chronic knee pain lasting for more than 6 months.

Ability to ambulate independently with or without an assistive device.

Disqualifiers

Severe knee osteoarthritis (grade IV) requiring imminent surgical joint replacement.

History of previous knee arthroplasty, internal fixation, or significant trauma to the affected lower extremity.

Presence of pacemakers, metallic implants in the knee region, or severe. - peripheral vascular disease (absolute contraindications for TECAR therapy).

Intra-articular injections (corticosteroids, platelet-rich plasma, or hyaluronic acid) into the knee within the past 3 months.

Trial design

Design model

Parallel

Treatments tested in this trial

  • True TECAR Therapy

    Device

    20 minutes per session (10 mins capacitive mode, 10 mins resistive mode), 3 sessions per week for 8 weeks will be applied around the affected knee joint. Thermal delivery will be adjusted to a comfortable, non-painful warm sensation

  • Sham TECAR

    Device

    The device will be applied using identical electrode placement, application time, and interface screen indicators, but with the power output disabled so that no current or deep thermal energy is transferred to the tissues.

  • Traditional Physiotherapy

    Other intervention

    Standardized knee osteoarthritis rehabilitation including progressive quad/hamstring strengthening, hip abductor strengthening, range of motion exercises, and flexibility training

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Study groupActive comparator 2 interventions
Group B: Control groupSham comparator 2 interventions

Trial outcomes

Primary outcomes

1

Pain Intensity

Visual Analog Scale will be used to assess pain intensity

Time frame
Baseline and after 8 weeks

Secondary outcomes

1

Balance

Berg Balance Scale will be used to assess balance

Time frame
Baseline and after 8 weeks
2

Health-Related Quality of Life

Short Form-12 Health Survey (SF-12) will be used to assess quality of life

Time frame
Baseline and after 8 weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Middle East University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: